Cabozantinib Related Compounds & Impurities

Cabozantinib is a multi-target kinase inhibitor blocking MET, VEGFR, AXL and RET, used for advanced renal cell, hepatocellular and thyroid cancers.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Cabozantinib reference standards, pharmacopeial and non-pharmacopeial Cabozantinib impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Cabozantinib-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

Pharmaceutical Reference Standards / Impurity Standards

Cabozantinib
Cabozantinib S Malate
Tivozanib Impurity 2
4-chloro-7-methoxyquinolin-6-ol
Cabozantinib Impurity 2
Cabozantinib Quinol Impurity
Cabozantinib Desfluoro Impurity
Cabozantinib 3 fluoro Impurity
Cabozantinib Impurity 7
Cabozantinib (s) Malate
N1,N2-Bis(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)oxalamide
Cabozantinib Impurity 9
Cabozantinib Hydroxy Impurity
Cabozantinib Carboxylic Acid
Cabozantinib N-oxide
Cabozantinib Impurity 6
Cabozantinib Impurity 20
Cabozantinib Impurity 19
Cabozantinib Impurity 36
N-(4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl)-N`-(4-fluorophenyl)-2-(2-hydroxyethyl)propanediamide
Cabozantinib impurity 23
Cabozantinib Impurity 22
Cabozantinib Impurity 16
Cabozantinib Impurity 25
Cabozantinib Chloro Impurity
Cabozantinib Impurity 27
Cabozantinib Impurity 26
Cabozantinib Impurity 5
Cabozantinib Impurity 12
Cabozantinib Impurity 27
Cabozantinib Desmethyl Impurity 1
N-Nitroso Cabozantinib Impurity 1
N-Nitroso Cabozantinib
Cabozantinib Nitroso Impurity 2
Cabozantinib Nitroso Impurity 3
Cabozantinib 6 Hydroxy Impurity
Cabozantinib Impurity 38
Open ring hydroxy Cabozantinib
Cabozantinib Impurity 4
Cabozantinib Impurity 8
Cabozantinib Impurity 3
Cabozantinib Impurity 10

Isotope Labelled Compounds

Cabozantinib D4
Cabozantinib D6